Search for: "W. T. Grant Co., in Re" Results 461 - 480 of 733
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Apr 2020, 6:03 am by Chris Wesner
The case arose from the Appellees, Kenneth W. [read post]
30 Jan 2009, 7:00 pm
(Patent Prospector)   US Patents Congress weighs patent specialisation for federal judges (Ars Technica) (Inventive Step) (Law360) (IP Spotlight) (Patent Prospector) M Lemley & B Sampat’s report ‘Examiner Characteristics and the Patent Grant Rate’ – experienced examiners allow more, cite less (Peter Zura's 271 Patent Blog) PTO problems are not new; the more things change, the more they stay the same (Inventive Step) Peer to… [read post]
4 Mar 2013, 12:38 am by Kevin LaCroix
Rather the court must interpret the disputed language in context, w with regard to its intended function in the policy. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
26 Jun 2015, 1:08 pm by John Elwood
Unless the Court abandons its policy of routinely relisting cases before granting, or there are new relists Monday morning that are promptly granted after a quickie mop-up Conference (as I write this, the Court’s schedule during the last days before recess is still in flux), these next five cases might be the last ones with a shot at a grant before the Long Conference. [read post]
29 Feb 2008, 8:00 am
, (EDTexweblog.com), (Patent Prospector), (Peter Zura's 271 Patent Blog), (IPBiz), (Against Monopoly), (Philip Brooks), (IPBiz), Indian government to consider whether to grant compulsory licenses to Natco for the exportation of generic versions of Tarceva and Sutent (Sunitinib) to Nepal : (Spicy IP), (Spicy IP), (Spicy IP), (Generic Pharmaceuticals & IP), (IP Law360), (Spicy IP),GlobalGlobal - GeneralIntellectual privilege or imaginary property? [read post]